1-20 of 948
Diffusion
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

DARA to Believe: Anti-CD38 Antibody Improves Outcomes in Relapsed/Refractory Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma

Free
Zachary Graff, MD, Lauren Pommert, MD, MS
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.202534
Published: 2025
Articles

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

Free
Emily Wolf, MD, Ewa Wysokinska, MD, Surbhi Shah, MBBS, MD
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.202535
Published: 2025
Articles

Debunking the Myth: Sickle Cell Trait and Exertion-Related Deaths — A Review of the Evidence

Free
Chinonso Onuoha, MD, Samuel R. Wilson, MD, MSCR, Patrick Ellsworth, MD
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.202536
Published: 2025
Articles

Does 1 + 1 = 2? Combining Targeted Agents in Frontline Chronic Lymphocytic Leukemia

Free
Tycel Phillips, MD
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.2025313
Published: 2025
Articles

Better Together? Combining Teclistamab and Talquetamab in RedirecTT-1

Free
Darren Pan, MD, Anupama D. Kumar, MD, Jodi J. Lipof, MD, Alfred Chung, MD, Ajai Chari, MD
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.2025311
Published: 2025
Articles

Best in Class? DLBclass, a New Classification Tool for Diffuse Large B-Cell Lymphoma to Facilitate Development of Molecular-Based Precision Treatments

Free
Brian T. Hill, MD, PhD
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.202532
Published: 2025
Articles

CRISPR-Based Diagnostic Assay for Acute Promyelocytic Leukemia

Free
Elizabeth L. Courville, MD
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.202531
Published: 2025
Articles

Will CAR T Cells Ever Work in Acute Myeloid Leukemia? Perhaps, If We Follow the Cytokines

Free
Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.202533
Published: 2025
Articles

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Free
Scott Furlan, MD
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.2025312
Published: 2025
Articles

First Relapse, Second Chance: Determinants of Survival After First Relapse in Pediatric Acute Lymphoblastic Leukemia

Free
Kristin Zorn, MD, Lauren Pommert, MD, MS
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.2025212
Published: 2025
Articles

Investigation of Patient With Monoclonal Gammopathy of Thrombotic Significance Unmasks New Type of Platelet-Activating Anti-Platelet Factor 4 Antibody

Free
Adam J. Kanack, PhD, Surbhi Shah, MBBS, Anand Padmanabhan, MBBS, PhD
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.2025213
Published: 2025
Articles

AQUILA: Dousing the Embers of Smoldering Multiple Myeloma With Daratumumab Monotherapy

Free
Jodi J. Lipof, MD, Darren Pan, MD, Anupama D. Kumar, MD, Alfred Chung, MD, Ajai Chari, MD
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.202523
Published: 2025
Articles

Obecabtagene Autoleucel Emerges as an Avenue for Adults With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Free
Gregory W. Roloff, MD, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.202525
Published: 2025
Articles

Beyond Complete Blood Count Reference Ranges: Exploring Hematologic Setpoints

Free
Elizabeth L. Courville, MD
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.202524
Published: 2025
Articles

PIVOTing to Hydroxyurea in Hemoglobin SC Disease

Free
Joshua G. Rivenbark, MD, PhD, Samuel R. Wilson, MD, MSCR
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.202527
Published: 2025
Articles

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

Free
Tycel Phillips, MD
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.202526
Published: 2025
Articles

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

Free
Michael Scott, MD
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.202528
Published: 2025
Articles

Hemolysis Be Gone: Iptacopan’s Role in Paroxysmal Nocturnal Hemoglobinuria

Free
Zoey I. Harris, MD, Surbhi Shah, MBBS, MD
Journal: The Hematologist
The Hematologist (2024) 21 (6)
https://doi.org/10.1182/hem.V21.6.2024612
Published: 2024
Articles

Targeting Cell Migration to Prevent Graft-Versus-Host Disease: A New Strategy

Free
Kate A. Markey, MBBS, PhD
Journal: The Hematologist
The Hematologist (2024) 21 (6)
https://doi.org/10.1182/hem.V21.6.202469
Published: 2024
Articles

Blinatumomab for B-ALL? Unraveling E1910 Trial Results for the Practicing Hematologist

Free
Marlise R. Luskin, MD, MSCE, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2024) 21 (6)
https://doi.org/10.1182/hem.V21.6.2024610
Published: 2024